The FDA has approved Shield, a blood test from California-based Guardant Health, which is designed to detect colorectal cancer. The test is expected to be covered by most insurance plans following approval. The FDA has approved Shield, a blood test from California-based Guardant Health, which is designed to detect colorectal cancer. The test is expected to be covered by most insurance plans following approval.
FDA approves new blood test to screen for colon cancer that should be covered by insurance: ‘It’s going to have a huge impact’
